Metraipolis › archive › dc_2ec6506afba3
Immune checkpoint inhibition in bone metastases: lesion response heterogeneity, the osteoimmune niche, and microenvironment-directed therapy — Europe PMC PMID:42824795
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42824795
- DOI
- 10.3389/fimmu.2026.1959101
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T09:37:42.149Z
- SHA-256 of the archived text
0655541338d3ac8a08696f9000ddd946282b011ea078a66d5c51fdc3d36fb339- Stable URL of this page
https://metraipolis.com/documento/dc_2ec6506afba3
How to cite
Immune checkpoint inhibition in bone metastases: lesion response heterogeneity, the osteoimmune niche, and microenvironment-directed therapy — Europe PMC PMID:42824795 — Europe PMC (en), https://europepmc.org/article/MED/42824795 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ec6506afba3 (Metraipolis archive dc_2ec6506afba3, sha256 0655541338d3ac8a08696f9000ddd946282b011ea078a66d5c51fdc3d36fb339)
BibTeX
@misc{dc2ec6506afba3,
title = {Immune checkpoint inhibition in bone metastases: lesion response heterogeneity, the osteoimmune niche, and microenvironment-directed therapy — Europe PMC PMID:42824795},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42824795},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ec6506afba3; sha256 0655541338d3ac8a08696f9000ddd946282b011ea078a66d5c51fdc3d36fb339},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42824795. Agents can read the archived copy with the MCP tool read_document.